- Home
- PGEN vs CZNC Comparison
PGEN vs CZNC Comparison
Compare PGEN & CZNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PGEN | CZNC |
|---|---|---|
| Founded | 1998 | 1864 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2B | 465.4M |
| IPO Year | 2013 | 2009 |
Fundamental Metrics
Financial Performance| Metric | PGEN | CZNC |
|---|---|---|
| Price | $7.00 | $26.13 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 5 | 1 |
| Target Price | $8.33 | ★ $23.50 |
| AVG Volume (30 Days) | ★ 4.1M | 58.8K |
| Earning Date | 05-13-2026 | 05-12-2026 |
| Dividend Yield | N/A | ★ 4.87% |
| EPS Growth | N/A | ★ N/A |
| EPS | 0.03 | ★ 0.81 |
| Revenue | ★ $230,981,000.00 | N/A |
| Revenue This Year | $1,115.92 | $3.11 |
| Revenue Next Year | $81.04 | N/A |
| P/E Ratio | $228.33 | ★ $32.06 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.99 | $18.87 |
| 52 Week High | $7.72 | $26.26 |
Technical Indicators
Market Signals| Indicator | PGEN | CZNC |
|---|---|---|
| Relative Strength Index (RSI) | 52.26 | 61.69 |
| Support Level | $6.60 | $25.00 |
| Resistance Level | $7.30 | $26.15 |
| Average True Range (ATR) | 0.27 | 0.47 |
| MACD | -0.09 | -0.03 |
| Stochastic Oscillator | 26.38 | 80.82 |
Price Performance
Historical ComparisonAbout PGEN Precigen Inc.
Precigen Inc is a commercial-stage biopharmaceutical company focused on developing precision medicines to improve the lives of patients, targeting immuno-oncology, autoimmune disorders, and infectious diseases using its proprietary and complementary technology platforms. These platforms support the development of gene programs, delivery through viral, non-viral, and microbe-based approaches, and control of gene expression for safety and efficacy. Its key platforms include AdenoVerse immunotherapy and UltraCAR-T, supported by the UltraPorator device for rapid and cost-effective manufacturing. Its clinical pipeline includes PRGN-2009, PRGN-3005, PRGN-3006, and PRGN-3007. Its reportable segments are Biopharmaceuticals and Exemplar.
About CZNC Citizens & Northern Corp
Citizens & Northern Corp is a community bank operating through its subsidiaries. It provides banking services, including deposit and loan products for personal and commercial customers. The bank also maintains a trust division that provides a wide range of financial services, such as 401(k) plans, retirement planning, estate planning, estate settlements and asset management.